Therapeutic Asset Ratings
409 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
hcw9218
Ovarian Cancer
Haider Mahdi
P2
CC
(46)
hlx43
Ovarian Cancer
Shanghai Henlius Biotech
P2
CC
(46)
Hydroxychloroquine
Ovarian Cancer
Medical University of South Carolina
P2
CC
(46)
IMMUNOGLOBULIN G1 (DE-450-LYSINE), ANTI-(HUMAN TYROSINE KINASE RECEPTOR AXL) (HUMAN-MUS MUSCULUS MONOCLONAL BA301 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BA301 .KAPPA.-CHAIN, DIMER, THIOETHER WITH N-(((4-((N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-L-VALY L-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-N-METHYL-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-2-PHENYLETHYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE
Ovarian Cancer
Canadian Cancer Trials Group
P2
CC
(46)
Inavolisib
Ovarian Cancer
Hoffmann-La Roche
P2
CC
(46)
INTERFERON-ALFA-2A
Ovarian Cancer
Kalinski, Pawel, MD, PhD
P2
CC
(46)
Lartesertib
Ovarian Cancer
EMD Serono Research & Development Institute, Inc.
P2
CC
(46)
LEVAMLODIPINE
Ovarian Cancer
Tyler J Curiel
P2
CC
(46)
ly3023414
Ovarian Cancer
Dana-Farber Cancer Institute
P2
CC
(46)
Micardis®
Ovarian Cancer
Tyler J Curiel
P2
CC
(46)
Minoxidil
Ovarian Cancer
Loyola University
P2
CC
(46)
N-(5-ISOQUINOLINESULFONYL)-1,4-PERHYDRODIAZEPINE
Ovarian Cancer
Zhejiang Provincial People's Hospital
P2
CC
(46)
Nesuparib
Ovarian Cancer
Onconic Therapeutics Inc.
P2
CC
(46)
PF-0704091
Ovarian Cancer
Pfizer
P2
CC
(46)
PF-07104091
Ovarian Cancer
Pfizer
P2
CC
(46)
qlc1101
Ovarian Cancer
Yongpeng Wang
P2
CC
(46)
rc48
Ovarian Cancer
Jiangsu Cancer Institute & Hospital
P2
CC
(46)
Riluzole
Ovarian Cancer
University of California, Irvine
P2
CC
(46)
Romiplostim
Ovarian Cancer
Peking University People's Hospital
P2
CC
(46)
Sctil
Ovarian Cancer
Peking Union Medical College Hospital
P2
CC
(46)
Shr-1701
Ovarian Cancer
Qinglei Gao
P2
CC
(46)
Sleeping Beauty Transposed Pbl
Ovarian Cancer
National Cancer Institute (NCI)
P2
CC
(46)
Tart Cherry
Ovarian Cancer
University of California, Davis
P2
CC
(46)
Tcr Transduced T-Cells
Ovarian Cancer
National Cancer Institute (NCI)
P2
CC
(46)
Tuvusertib
Ovarian Cancer
EMD Serono Research & Development Institute, Inc.
P2
CC
(46)
Showing 151 to 175 of 409 assets
Previous
Page 7 of 17
Next